Vitamin Shoppe (NYSE:VSI) Upgraded by ValuEngine to “Buy”

ValuEngine upgraded shares of Vitamin Shoppe (NYSE:VSI) from a hold rating to a buy rating in a report released on Thursday, ValuEngine reports.

Separately, Zacks Investment Research downgraded Vitamin Shoppe from a buy rating to a hold rating in a research note on Friday, November 8th.

Vitamin Shoppe stock traded up $0.02 during trading on Thursday, hitting $6.49. The stock had a trading volume of 156,180 shares, compared to its average volume of 315,902. Vitamin Shoppe has a 1 year low of $3.32 and a 1 year high of $8.26. The company has a quick ratio of 0.21, a current ratio of 1.16 and a debt-to-equity ratio of 2.34. The stock’s 50 day moving average is $6.50 and its two-hundred day moving average is $5.44. The stock has a market cap of $156.40 million, a price-to-earnings ratio of 24.96 and a beta of 1.59.

Institutional investors have recently bought and sold shares of the stock. State of Alaska Department of Revenue lifted its stake in Vitamin Shoppe by 124.6% in the third quarter. State of Alaska Department of Revenue now owns 11,834 shares of the specialty retailer’s stock valued at $77,000 after purchasing an additional 6,564 shares during the last quarter. Cetera Advisors LLC purchased a new stake in shares of Vitamin Shoppe during the second quarter worth $47,000. Smith Asset Management Group LP purchased a new stake in shares of Vitamin Shoppe during the second quarter worth $99,000. Pacer Advisors Inc. lifted its position in shares of Vitamin Shoppe by 14.2% during the second quarter. Pacer Advisors Inc. now owns 42,666 shares of the specialty retailer’s stock worth $168,000 after acquiring an additional 5,303 shares in the last quarter. Finally, Crossmark Global Holdings Inc. lifted its position in shares of Vitamin Shoppe by 6.9% during the second quarter. Crossmark Global Holdings Inc. now owns 44,680 shares of the specialty retailer’s stock worth $176,000 after acquiring an additional 2,890 shares in the last quarter. Institutional investors and hedge funds own 95.37% of the company’s stock.

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.

Further Reading: Market Indexes

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.